- From: Tony Burdett <tburdett@ebi.ac.uk>
- Date: Wed, 31 Oct 2018 17:54:49 +0000
- To: "Gray, Alasdair J G" <A.J.G.Gray@hw.ac.uk>
- Cc: "public-bioschemas@w3.org" <public-bioschemas@w3.org>
Hi Alasdair, On 31/10/2018 14:12, Gray, Alasdair J G wrote: > >> Speaking for the samples group, I don't think everyone involved has >> had time to evaluate the impact of this proposal on the samples >> driving usecases, including the MarRef deployment and Biobanks >> exchange work. At first reading I think this will make it harder to >> demonstrate utility for these deployments. If the samples usecases >> were deprioritized in favour of other more compelling examples, >> that's reasonable, but the proposal document doesn't indicate how >> this was determined and I'd like to have a chance to review the >> results of that decision-making process. > > Sample was not prioritised at this point as I felt that we had a > strong working example of this being used in live deployment based on > the BioChemEntity, i.e. Sample has not been deprioritised. I do not > believe that the proposal would affect Sample profile or the > deployments, but please correct me if I am wrong. My intention had > been to follow up with the Sample group, but time has not permitted > this to happen. We are more than happy to have discussions on whether > there is a need for a Sample type. Melanie is doing a more detailed analysis now and commenting on the proposal document. The existing Sample deployments require some mechanism to identify those BioChemEntities that are samples (whether this is via a property describing the type as an ontology URI or having a dedicated Sample type doesn't really matter, but the MarRef implementation assumes Sample as a new type) and the ability to link from PropertyValue to CategoryCode. We've built implementations on the assumption these will form part of the proposal and I think it would be good to keep these in order to send the right message to those early adopters who are using bioschemas markup for something other than search indexing. Thanks, Tony -- Tony Burdett Technical Co-ordinator - Samples, Phenotypes and Ontologies Team, European Bioinformatics Institute (EMBL-EBI) European Molecular Biology Laboratory Wellcome Trust Genome Campus Hinxton Cambridge CB10 1SD United Kingdom Tel: + 44 (0) 1223 494 624
Received on Wednesday, 31 October 2018 17:55:55 UTC